Literature DB >> 1489407

Hodgkin's lymphoma. II: Treatment and delayed morbidity.

P Carde1.   

Abstract

Entities:  

Mesh：

Year:  1992        PMID： 1489407      PMCID： PMC1883215          DOI： 10.1136/bmj.305.6846.173

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  37 in total

1.  Survival outcome after Hodgkin's disease: a report from the international data base on Hodgkin's disease.

Authors:  M Henry-Amar; R Somers
Journal:  Semin Oncol       Date:  1990-12       Impact factor: 4.929

2.  Protective effect of medroxyprogesterone acetate plus testosterone against radiation-induced damage to the reproductive function of male rats and their offspring.

Authors:  B Jégou; J F Velez de la Calle; F Bauché
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

3.  ICRF-187 permits longer treatment with doxorubicin in women with breast cancer.

Authors:  J L Speyer; M D Green; A Zeleniuch-Jacquotte; J C Wernz; M Rey; J Sanger; E Kramer; V Ferrans; H Hochster; M Meyers
Journal:  J Clin Oncol       Date:  1992-01       Impact factor: 44.544

Review 4.  Primary and salvage chemotherapy in advanced Hodgkin's disease: the Milan Cancer Institute experience.

Authors:  G Bonadonna; A Santoro; A M Gianni; S Viviani; S Siena; M Bregni; R Zucali; F Lombardi; V Bonfante; L Gianni
Journal:  Ann Oncol       Date:  1991-01       Impact factor: 32.976

5.  MACOP-B and VACOP-B in diffuse large cell lymphomas and MOPP/ABV in Hodgkin's disease.

Authors:  S E O'Reilly; P Hoskins; P Klimo; J M Connors
Journal:  Ann Oncol       Date:  1991-01       Impact factor: 32.976

6.  Pericarditis and myocardial infarctions after Hodgkin's disease therapy.

Authors:  J M Cosset; M Henry-Amar; B Pellae-Cosset; P Carde; T Girinski; M Tubiana; M Hayat
Journal:  Int J Radiat Oncol Biol Phys       Date:  1991-07       Impact factor: 7.038

7.  Suppression of thromboxane A2 but not of systemic prostacyclin by controlled-release aspirin.

Authors:  R J Clarke; G Mayo; P Price; G A FitzGerald
Journal:  N Engl J Med       Date:  1991-10-17       Impact factor: 91.245

8.  Recombinant granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid cancer.

Authors:  J Nemunaitis; S N Rabinowe; J W Singer; P J Bierman; J M Vose; A S Freedman; N Onetto; S Gillis; D Oette; M Gold
Journal:  N Engl J Med       Date:  1991-06-20       Impact factor: 91.245

Review 9.  Therapy-related acute myeloid leukemia secondary to inhibitors of topoisomerase II: from the bedside to the target genes.

Authors:  M J Ratain; J D Rowley
Journal:  Ann Oncol       Date:  1992-02       Impact factor: 32.976

10.  The results of radiotherapy for Hodgkins' disease.

Authors:  M J Peckham; H T Ford; T J McElwain; C L Harmer; K Atkinson; D E Austin
Journal:  Br J Cancer       Date:  1975-09       Impact factor: 7.640
View more
  1 in total

1.  Treatment of Hodgkin's lymphoma.

Authors:  A McMillan; R Pearce; R Chopra; A H Goldstone; D C Linch
Journal:  BMJ       Date:  1992-08-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.